Novartis AG (NOTA) Stock Price & News

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

About Novartis AG

CEOVasant Narasimhan

Employees75.3 мян

Founded1996 оны 3-р сарын 7

HeadquartersБазель хот, Basel City, Швейцари

SectorPharmaceutical industry

Websitenovartis.com

Revenue

Net income

All values in USD	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар
Revenue	14.36 тэрбум	13.86 тэрбум	13.52 тэрбум	14.95 тэрбум
Cost of goods sold	3.54 тэрбум	3.54 тэрбум	3.44 тэрбум	3.68 тэрбум
Cost of revenue	3.54 тэрбум	3.54 тэрбум	3.44 тэрбум	3.68 тэрбум
Research and development expenses	2.86 тэрбум	2.84 тэрбум	2.78 тэрбум	2.74 тэрбум
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.30 тэрбум	3.44 тэрбум	3.14 тэрбум	3.23 тэрбум
Operating expense	6.24 тэрбум	6.46 тэрбум	5.96 тэрбум	6.10 тэрбум
Total operating expenses	9.77 тэрбум	10.00 тэрбум	9.40 тэрбум	9.78 тэрбум
Operating income	4.58 тэрбум	3.86 тэрбум	4.12 тэрбум	5.18 тэрбум
Other non operating income	-7.00 сая	-130.00 сая	4.00 сая	19.00 сая
EBT including unusual items	4.20 тэрбум	3.22 тэрбум	3.84 тэрбум	4.27 тэрбум
EBT excluding unusual items	4.29 тэрбум	3.49 тэрбум	3.78 тэрбум	4.73 тэрбум
Income tax expense	266.00 сая	814.00 сая	683.00 сая	1.01 тэрбум
Effective tax rate	6.34%	25.30%	17.79%	23.71%
Other operating expenses	70.00 сая	190.00 сая	42.00 сая	127.00 сая
Net income	3.93 тэрбум	2.41 тэрбум	3.16 тэрбум	3.26 тэрбум
Net profit margin	27.36%	17.38%	23.34%	21.83%
Earnings per share	2.25	2.03	1.99	2.41
Interest and investment income	-	373.00 сая	-	-
Interest expense	-281.00 сая	-304.00 сая	-343.00 сая	-462.00 сая
Net interest expenses	-281.00 сая	69.00 сая	-343.00 сая	-462.00 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	5.78 тэрбум	4.96 тэрбум	5.24 тэрбум	6.30 тэрбум
Gain or loss from assets sale	81.00 сая	80.00 сая	-159.00 сая	-247.00 сая

Ask anything